Cravatex Q1 FY27: consolidated revenue up 39%, swings to profit

Revenue Growth 20pctPat Growth 25pctResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.7%Reaction day

₹349.10

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-1.9% vs market

Trading & Distributors peers, median of 131sector+0.0%-1.7% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 1.7 pts less than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.7+0.2-1.9+0.0-1.7

Next day

-0.3+0.2-0.5-0.0-0.3

—+0.4—-0.4—

—+0.7—-1.2—

—+0.1—-1.3—

—+0.7—-1.1—

—+1.2—-1.3—

15d

—+0.7—-2.3—

—-1.2—-4.3—

—-1.1—-6.7—

—————

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 131Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Cravatex board approved Q1 FY27 unaudited results. Consolidated revenue from operations rose 39% YoY to Rs 3,222.45 lacs (vs Rs 2,312.69 lacs). Consolidated PAT swung to Rs 43.81 lacs profit from Rs 136.77 lacs loss YoY. Standalone revenue flat at Rs 144.49 lacs; standalone PAT fell to Rs 41.08 lacs (vs Rs 44.21 lacs). EPS consolidated Rs 1.70 vs Rs (5.29). Auditors gave unmodified review opinion.

Likely market impact

Strong consolidated revenue jump and swing to profit are positives; standalone stayed flat. Clean auditor opinion.